Medical News

RSS

Gastrolyzer® interpretation chart update

Included with every Gastrolyzer® range order, Bedfont® Scientific Limited provides practical resources designed to support and simplify hydrogen and methane breath testing (HMBT).

From Bedfont® Scientific Ltd 11 May 2026

Brain artery widening may drive lacunar stroke more than artery narrowing

Abnormal brain artery widening is associated with lacunar stroke, indicating a shift in understanding the mechanisms behind small vessel disease in the brain.

11 May 2026

Endometriosis linked to slightly higher birth defect risk in infants

For babies born to people with endometriosis, there is a small but significant increased risk of congenital anomalies, often called birth defects, according to new research in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.250439.

11 May 2026

Andes hantavirus outbreak highlights global spillover and transmission risks

A Virginia Tech disease ecologist said the outbreak of Andes hantavirus aboard the international MV Hondius cruise ship underscores how little scientists still know about the viruses circulating silently in wild rodent populations before they spill into humans.

11 May 2026

New obesity drugs may shift blame toward food industry

An essay presented at this year's European Congress on Obesity in Istanbul, Turkey (12-15 May) suggests that new age of obesity drugs could shift the blame for living with obesity from individuals to the food industry – just as smoking has been blamed on tobacco industry and to a lesser extent alcohol consumption on the alcohol industry.

11 May 2026

Longer working hours linked to rising obesity across OECD countries

A new study presented at this year's European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12-15 May) shows that a 1% reduction in annual working hours is associated with a 0.16% decrease in obesity rates across OECD countries.

11 May 2026

Semaglutide shows sustained weight loss benefits in older adults

A new analysis of the STEP trails carried out by semaglutide manufacturer Novo Nordisk has analysed various trials to show the safety and efficacy of the obesity drug semaglutide in older adults (over 65 years), and found similar efficacy and safety as in the general trial populations .

11 May 2026

Eating out regularly linked to higher obesity risk worldwide

New research to be presented at this year's European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May) suggests that no matter where people live, eating out instead of preparing meals at home is linked to weight gain and obesity.

11 May 2026

Daily orforglipron treatment reduces weight and blood sugar in seniors

A new analysis to be presented at this year's European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May) examined daily oral orforglipron treatment for the treatment of obesity, with or without diabetes, in users aged 65 years and over, with results and a safety profile similar to that seen in the ATTAIN clinical trial programme population.

11 May 2026

Prenatal progesterone exposure alters brain development genes in male fetuses

Excessive exposure to progesterone in the womb can alter a gene in the frontal cortex in male sheep fetuses, which is needed for brain development and function, according to research presented at the 28th European Congress of Endocrinology in Prague.

11 May 2026

Heart disease risk increases in women with polycystic ovary syndrome

Heart disease risk has been found to increase in women with polycystic ovary syndrome (PCOS), even in those with normal weight, according to research presented at the 28th European Congress of Endocrinology in Prague.

10 May 2026

Atomic-level images could improve future COVID-19 antiviral drug design

The closest-ever detailed look at a key enzyme inside the virus that causes COVID-19 could lead to more effective treatment of the disease.

10 May 2026

Greater weight loss from GLP-1 drugs lowers health complication risk

New research to be presented at this year's European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May) shows that, following treatment for obesity or diabetes or both using incretin-based drugs, losing more weight versus less weight, and losing a little weight versus gaining weight, both lead to relatively lower risk of obesity-related conditions.

10 May 2026

Children frequently pressure parents to buy unhealthy foods during shopping

A study using a nationally representative survey of parents in England, to be presented at this year's European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May), reveals that over half (58%) of parents are frequently pestered by their children or teens to purchase products high in fats, salts and/or sugar (HFSS) when food shopping in stores or online, and almost three-quarters (72%) reported often buying the requested item.

10 May 2026

Did COVID-19 reshape fatherhood? New study finds Filipino dads stepped back, not up, after lockdown

A longitudinal study of 307 Filipino fathers found that COVID-19 lockdowns did not produce lasting increases in paternal caregiving, with routine care actually declining post-pandemic. Shifts in employment status emerged as the strongest predictor of changes in fathers' time spent with their children.

10 May 2026

Walking 8,500 steps daily may help prevent weight regain

New research being presented at this year's European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12-15 May) and published in International Journal of Environmental Research and Public Health shows that doing around 8,500 steps a day can help people keep weight off after dieting.

10 May 2026

Targeted mitochondrial therapy accelerates healing of diabetic chronic wounds

Impaired mitophagy and the accumulation of damaged mitochondria are key drivers of endothelial cell (EC)dysfunction in diabetic wounds.

10 May 2026

Study reveals immune differences between titanium and zirconia implants

Zirconia is widely regarded as a promising alternative to titanium for bone and dental implants because of its aesthetic advantages, biocompatibility, and potential to reduce metal ion release.

10 May 2026

Copper-based nanoplatform shows promise against metastatic tumor growth

What happens if cancer cells lose both their mitochondrial energy supply and their glycolytic backup system? This question is central to a new study published in Research by researchers from Northwestern Polytechnical University and collaborating institutions.

10 May 2026